These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 15970709)
1. Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells. Wang Z; Xie Y; Wang H Cancer Biol Ther; 2005 Jul; 4(7):716-9. PubMed ID: 15970709 [TBL] [Abstract][Full Text] [Related]
2. MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. Ren L; Xiao L; Hu J J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):721-4. PubMed ID: 18231753 [TBL] [Abstract][Full Text] [Related]
3. [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM]. Deng KX; Zhong L; Jiang MX; Wang PL; Chen Y Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):836-9. PubMed ID: 16412331 [TBL] [Abstract][Full Text] [Related]
4. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP]. Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253 [TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effects of survivin antisense oligonucleotide on drug-resistant human ovarian cancer cell COC1/DDP]. Ruan F; Xie XK; Liu SY Ai Zheng; 2004 Aug; 23(8):896-9. PubMed ID: 15301710 [TBL] [Abstract][Full Text] [Related]
6. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel]. Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669 [TBL] [Abstract][Full Text] [Related]
7. [Reversal effect of Fe3O4-magnetic nanoparticles on multi-drug resistance of ovarian carcinoma cells and its correlation with apoptosis-associated genes]. Jiang Z; Chen BA; Wu Q; Xia GH; Zhang Y; Gao F; Hong TY; Xu CR; Cheng J; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM Ai Zheng; 2009 Nov; 28(11):1158-62. PubMed ID: 19895735 [TBL] [Abstract][Full Text] [Related]
8. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving. Wang DY; Li N; Cui YL Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801 [TBL] [Abstract][Full Text] [Related]
10. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel]. Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin. Komuro Y; Udagawa Y; Susumu N; Aoki D; Kubota T; Nozawa S Jpn J Cancer Res; 2001 Nov; 92(11):1242-50. PubMed ID: 11714450 [TBL] [Abstract][Full Text] [Related]
12. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084 [TBL] [Abstract][Full Text] [Related]
13. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells]. Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448 [TBL] [Abstract][Full Text] [Related]
14. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398 [TBL] [Abstract][Full Text] [Related]
15. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer]. Tang XH; Lu MS; Deng S; Li M Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574 [No Abstract] [Full Text] [Related]
16. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763 [TBL] [Abstract][Full Text] [Related]
18. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP]. Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863 [TBL] [Abstract][Full Text] [Related]
19. [Influence of human epithelial ovarian cancer HO-8910 cells with modified survivin gene on the cell cycle distribution and chemosensitivity]. Peng LP; Huang JM; Zhang GN; Zha X; Ren Y; Fan Y; Deng BF Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):860-4. PubMed ID: 21211287 [TBL] [Abstract][Full Text] [Related]
20. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines]. Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]